Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael J Wan, Ka Lo Chan, Benjamin G Jastrzembski & Asim Ali. (2019) Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives. Eye and Brain 11, pages 13-23.
Read now
Read now
Articles from other publishers (11)
Michal Grzmil, Stefan Imobersteg, Alain Blanc, Stephan Frank, Roger Schibli & Martin P. Béhé. (2021) Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N. Pharmaceutics 13:12, pages 2156.
Crossref
Crossref
Paul Calame, Gaëlle Tyrode, Delphine Weil Verhoeven, Sophie Félix, Anne Julia Klompenhouwer, Vincent Di Martino, Eric Delabrousse & Thierry Thévenot. (2021) Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: A literature review. World Journal of Gastroenterology 27:19, pages 2299-2311.
Crossref
Crossref
Priti Jain, Shreyans K. Jain & Munendra Jain. (2021) Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies. Current Molecular Medicine 21:2, pages 111-132.
Crossref
Crossref
Paolo Frassanito, Carolina Noya & Gianpiero Tamburrini. (2020) Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis. Child's Nervous System 36:10, pages 2527-2536.
Crossref
Crossref
Yeru Chen, Piao Zhang, Xianyi Lin, Huan Zhang, Jiamin Miao, Youfa Zhou & Gang Chen. (2020) Mitophagy impairment is involved in sevoflurane-induced cognitive dysfunction in aged rats. Aging 12:17, pages 17235-17256.
Crossref
Crossref
Sergiusz Jozwiak, Katarzyna Kotulska, Michael Wong & Martina Bebin. (2020) Modifying genetic epilepsies – Results from studies on tuberous sclerosis complex. Neuropharmacology 166, pages 107908.
Crossref
Crossref
Jingxuan Fu, Hui Wang, Jing Gao, Mei Yu, Rubin Wang, Zhuo Yang & Tao Zhang. (2016) Rapamycin Effectively Impedes Melamine-Induced Impairments of Cognition and Synaptic Plasticity in Wistar Rats. Molecular Neurobiology 54:2, pages 819-832.
Crossref
Crossref
Peter Chin Wan Fung & Regina Kit Chee Kong. (2017) The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines. Journal of Cancer Therapy 08:11, pages 962-1029.
Crossref
Crossref
Marie Szymanowski, Maria Salomon Estebanez, Raja Padidela, Bing Han, Karolina Mosinska, Adam Stevens, Lena Damaj, Florence Pihan-Le Bars, Emilie Lascouts, Rachel Reynaud, Catherine Ferreira, Claire Bansept, Pascale de Lonlay, Cécile Saint-Martin, Mark J. Dunne, Indraneel Banerjee & Jean-Baptiste Arnoux. (2016) mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success. The Journal of Clinical Endocrinology & Metabolism 101:12, pages 4719-4729.
Crossref
Crossref
Xiaojun Zha, Zhongdong Hu, Shuang Ji, Fuquan Jin, Keguo Jiang, Chunjia Li, Pan Zhao, Zhenzhen Tu, Xianguo Chen, Lijun Di, Haisheng Zhou & Hongbing Zhang. (2015) NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth. Cancer Letters 359:1, pages 97-106.
Crossref
Crossref
Amulya A. Nageswara Rao & Roger J. Packer. (2014) Advances in the Management of Low-Grade Gliomas. Current Oncology Reports 16:8.
Crossref
Crossref